Delisting riskPopularity #4,022
Jaguar Health (JAGX)
Develops and supplies crofelemer treatments for intestinal failure and diarrhea in people and animals.
$8.89
vs last close−25.57 (−74.20%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 0.14% | 488 shares | |
|---|---|---|---|
| 10 holders · as of Mar 31, 2026 | |||
| Insiders | 0.06% | 198 shares | |
| 9 holders · as of Mar 12, 2026 | |||
| Other | 99.80% | 343.9K shares | |
| remainder | |||
344.6K company shares as of Sep 23, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
Two share counts disagree (344.6K in the company's Sep 23, 2026 report, 434.1K elsewhere); stakes use the report.
13F, as of Mar 31, 2026
10 holders · 256.1K shares · 3 new positions · 6 increased · 1 reduced · 4 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| UBS Group AG | 112.9K | 32.77% | +106.5K | May 5, 2026 |
| Geode Capital Management, LLC | 110.1K | 31.96% | +86.1K | May 15, 2026 |
| HRT Financial LP | 15.2K | 4.41% | +15.2Knew | May 14, 2026 |
| Two Sigma Securities, LLC | 12.6K | 3.64% | +12.6Knew | May 15, 2026 |
| Sbi Securities Co., Ltd. | 2.6K | 0.75% | +2.4K | Apr 28, 2026 |
| Tower Research Capital LLC (TRC) | 2.3K | 0.67% | −1.3K | May 15, 2026 |
| Wells Fargo & Company/MN | 200 | 0.06% | +200new | Jul 8, 2026 |
| Leonteq Securities AG | 188 | 0.05% | 0 | Apr 27, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| John Fife and Fredrick Waid | 9.90% | 13G | Jan 29, 2025 | |
| Iliad Research & Trading, L.P. | 9.80% | 13G | Dec 11, 2025 | |
| Joshua Mailman | 8.40% | 13G | Jan 5, 2026 |
Form 4
Latest trades
No open-market trades in the last 12 months.
House and Senate disclosures
Not reported.